At least 197 European children born from an anonymous sperm donor face a high cancer risk because the biological father unknowingly carries Li-Fraumeni syndrome, Corriere della sera reported.
The rare hereditary condition stems from mutations in the TP53 gene and dramatically increases the likelihood of developing multiple tumors, often at an early age. Some children born from the donor have already died from cancer, and only a minority of those who inherit the mutation will escape the disease during their lifetime.
The syndrome was first identified in 1969 by American physicians Frederick Pei Li and Joseph F. Fraumeni Jr. after they noticed an unusual clustering of specific cancers in certain families, particularly childhood rhabdomyosarcomas. The condition results from mutations in the TP53 gene, which produces the p53 protein responsible for tumor suppression. Patients face heightened risks for sarcomas, leukemias, breast cancer, glioblastomas, and tumors of the adrenal gland and colon.
Cordisco said that a high probability does not mean absolute certainty, and some carriers never fall ill. Because many carriers have no family history or prior genetic counseling, individuals can remain completely unaware of the mutation.
Recent data contrast past prevalence estimates for the condition with updated scientific findings. While older estimates placed the general population frequency between 1 in 5mila and 1 in 20mila births, a recent study indicates a frequency of 1 in 3,555 to 1 in 5,476 births.
| Metric | Previous Estimate | Recent Study |
|---|---|---|
| Estimated Italian Carriers | Not specified | 11mila – 17mila |
| Male Lifetime Cancer Risk | Not specified | At least 70% |
| Female Lifetime Cancer Risk | Not specified | At least 90% |
Carriers of the TP53 mutation require dedicated medical monitoring to detect malignancies at an earliest possible stage. Patients undergo annual total-body magnetic resonance imaging scans to screen all tissues and organs. Family members also undergo genetic counseling to determine their mutation status.
She added that affected individuals receive specialized surveillance pathways while their relatives check for inherited risks.
The condition typically lacks early warning symptoms. Diagnosis relies on identifying abnormal cancer patterns, such as multiple primary tumors occurring in the same family before age 30.
Central nervous system structures, breasts, adrenal glands, bones, soft tissues, and hematopoietic systems show the highest vulnerability, alongside risks for gastrointestinal, pulmonary, and thyroid cancers.
Born in 1933, Joseph F. Fraumeni Jr. built a career centered at the National Cancer Institute, where he served as a commissioned officer starting in 1962 and later became the founding Director of the Division of Cancer Epidemiology and Genetics in 1995. His long-term dedication to the field included tracing affected families for twenty years to characterize the syndrome and identifying the underlying role of the p53 gene mutation in 1990.
Lifetime cancer risk reaches at least 70% for men and at least 90% for women, with the higher female percentage driven largely by breast cancer susceptibility.
Keep reading